A citation-based method for searching scientific literature

Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Christian T Ruff, Ingrid A M Gause-Nilsson, Martin Fredriksson, Peter A Johansson, Anna-Maria Langkilde, Marc S Sabatine. N Engl J Med 2019
Times Cited: 2333



Carlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena-Ibanez, Alvaro Garcia-Ropero, Donna Mancini, Sean Pinney, Frank Macaluso, Samantha Sartori, Merce Roque, Fernando Sabatel-Perez, Anderly Rodriguez-Cordero, M Urooj Zafar, Icilma Fergus, Farah Atallah-Lajam, Johanna P Contreras, Cathleen Varley, Pedro R Moreno, Vivian M Abascal, Anuradha Lala, Ronald Tamler, Javier Sanz, Valentin Fuster, Juan J Badimon. J Am Coll Cardiol 2021
Times Cited: 106




List of shared articles



Times cited


Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence.
Jose S Aguilar-Gallardo, Ashish Correa, Johanna P Contreras. Eur Heart J Cardiovasc Pharmacother 2022
2

Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
Mads Ersbøll, Mikkel Jürgens, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Niels H Brandt-Jacobsen, Peter Gæde, Peter Rossing, Jens Faber,[...]. Int J Cardiovasc Imaging 2022
1

Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
Nan Zhang, Yueying Wang, Gary Tse, Panagiotis Korantzopoulos, Konstantinos P Letsas, Qingpeng Zhang, Guangping Li, Gregory Y H Lip, Tong Liu. Eur J Prev Cardiol 2022
8

Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis.
Trevor Yeong, Aaron Shengting Mai, Oliver Z H Lim, Cheng Han Ng, Yip Han Chin, Phoebe Tay, Chaoxing Lin, Mark Muthiah, Chin Meng Khoo, Mayank Dalakoti,[...]. ESC Heart Fail 2022
1

Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects.
Jason R B Dyck, Samuel Sossalla, Nazha Hamdani, Ruben Coronel, Nina C Weber, Peter E Light, Coert J Zuurbier. J Mol Cell Cardiol 2022
3

Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients.
João Reis, Ana Rita Teixeira, António Valentim Gonçalves, Rita Ilhão Moreira, Tiago Pereira Silva, Ana Teresa Timóteo, Rui Cruz Ferreira. J Clin Med 2022
0

Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review.
Mauro Gitto, Dimitrios A Vrachatis, Gianluigi Condorelli, Konstantinos Papathanasiou, Bernhard Reimers, Spyridon Deftereos, Giulio G Stefanini. Cardiovasc Hematol Agents Med Chem 2022
0

Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function.
Fang-Hong Shi, Hao Li, Long Shen, Li Xu, Heng Ge, Zhi-Chun Gu, Hou-Wen Lin, Jun Pu. J Clin Endocrinol Metab 2022
0